ACCESS Newswire

/ PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s

Breaking News

The international financial community maintains a highly positive outlook on the economic trajectory of the United Arab Emirates. Recent macroeconomic assessments published by the World Bank Group indicate that the sovereign state will experience robust expansion over the next two